Acurx Pharmaceuticals (3ZO0) Q2 2025 Earnings Report
DE:3ZO0 Q2 2025 EPS Results
- Actual EPS
- -EUR 1.69
- Consensus EPS
- -EUR 2.09
- Beat/Miss
- Beat by +EUR 0.40
- One Year Ago EPS
- -EUR 4.65
DE:3ZO0 Q2 2025 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/12/2025
- Time
- Before Open
- Conference Call
- Tuesday, August 12, 2025
DE:3ZO0 Upcoming Earnings
Acurx Pharmaceuticals's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q2 2025 Earnings Call Audio
DE:3ZO0 Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:3ZO0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q3) | -0.34- | -1.1 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | -0.34-0.47 | -1.69 | 71.96% (+1.22) | |
| May 12, 2026 | 2026 (Q1) | -1.07-0.55 | -1.97 | 71.82% (+1.41) | |
| Mar 13, 2026 | 2025 (Q4) | -0.91-0.65 | -2.86 | 77.19% (+2.21) | |
| Nov 12, 2025 | 2025 (Q3) | -1.17-1.10 | -3.04 | 63.82% (+1.94) | |
| Aug 12, 2025 | 2025 (Q2) | -2.09-1.69 | -4.65 | 63.65% (+2.96) | |
| May 13, 2025 | 2025 (Q1) | -2.32-1.97 | -5.01 | 60.71% (+3.04) | |
| Mar 18, 2025 | 2024 (Q4) | -3.13-2.86 | -6.62 | 56.76% (+3.76) | |
| Nov 13, 2024 | 2024 (Q3) | -2.59-3.04 | -4.29 | 29.17% (+1.25) | |
| Aug 09, 2024 | 2024 (Q2) | -2.95-4.65 | -5.01 | 7.14% (+0.36) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
